Celldex Therapeutics, Inc. · Needham, MA United States (NASDAQ: CLDX)
| 119 4th Ave. | Phone: 781-433-0771 |
| Needham, MA | Fax: 781-433-0262 |
| 02494 | |
| United States | 
Map This Company |
Celldex Therapeutics, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Celldex Therapeutics develops immunotherapies to treat specific forms of cancer, autoimmune diseases, and infections. The biopharmaceutical company's Precision Targeted Immunotherapeutics platform uses monoclanal antibodies, antibody-targeted vaccines, and immune system modulator to create disease-specific drugs. Two of its lead candidates are in clinical development for the treatment of brain cancer (CDX-110) and melanoma and breast cancer (CDX-011). Celldex takes candidates through earlier stages of development, then typically seeks partners to usher them through late stages. Formerly AVANT Immunotherapeutics, the company merged with
Celldex Therapeutics, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: CLDX Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 100 |
Executives
18 executives listed for Celldex Therapeutics, Inc.'s Needham, MA location.
| Chairman | Larry Ellberger | |
|---|---|---|
| President, CEO, and Director | Anthony Marucci | |
| SVP, CFO, and Secretary | Avery Catlin |